Health Care & Life Sciences » Biotechnology | REGENXBIO Inc.

REGENXBIO Inc.

REGENXBIO Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $1.04
Market Cap
 $1.74 B
Shares Outstanding
 36.64 M
Public Float
 33.62 M

Profile

Address
9600 Blackwell Road
Rockville Maryland 20850
United States
Employees -
Website http://www.regenxbio.com
Updated 07/08/2019
REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M.

Financials

View All
Created with Highcharts 5.0.14REGENXBIO Inc.Net Income. Fiscal year is January-December. All values USD Thousands.5 3875 3874 0034 00322 81122 81162 96762 96773 16973 16999 93799 937201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14REGENXBIO Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.6 0876 0876 1206 1207 5887 5884 5894 58910 39310 393218 505218 505201320142015201620172018050k100k150k200k250k

Donald J. Hayden
Chairman
Kenneth T. Mills
President, Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.